Cardiovascular preparticipation screening of competitive athletes: A statement for health professionals from the Sudden Death Committee (Clinical cardiology) and Congenital Cardiac Defects Committee (Cardiovascular disease in the young), American Heart Association

Circulation

Volumn 94, Issue 4, 1996, Pages 850-856

  Maron, Barry J ^a   Thompson, Paul D ^a   Puffer, James C ^a   McGrew, Christopher A ^a   Strong, William B ^a   Douglas, Pamela S ^a   Clark, Luther T ^a   Mitten, Matthew J ^a   Crawford, Michael H ^a   Atkins, Dianne L ^a   Driscoll, David J ^a   Epstein, Andrew E ^a  

^a NONE

Author keywords

AHA Medical Scientific Statements; exercise; sudden death

Indexed keywords

ATHLETE; CARDIOVASCULAR DISEASE; ECHOCARDIOGRAPHY; HUMAN; LAW; MEDICAL ETHICS; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE; REVIEW; SCREENING TEST; SUDDEN DEATH;

EID: 9544232535     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.4.850     Document Type: Review

References (71)

1. Maron BJ. Sudden death in young athletes: lessons from the Hank Gaithers affair. N Engl J Med. 1993;329:55-57.
2. Burke AP, Farb A, Virmani R, Goodin J, Smialek JE. Sports-related and non-sports-related sudden cardiac death in young adults. Am Heart J. 1991;121:568-575.
3. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes: clinical, demographic and pathological profiles. JAMA. 1996;276:199-204.
4. Van Camp SP, Bloor CM, Mueller FO, Cantu RC, Olson HG. Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc. 1995;27:641-647.
5. Maron BJ, Roberts WC, McAllister HA, Rosing DR, Epstein SE. Sudden death in young athletes. Circulation. 1980;62:218-229.
6. Corrado D, Thiene G, Nava A, Rossi L, Pennelli N. Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med. 1990;89:588-596.
7. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318:129-133.
8. Tsung SH, Huang TY, Chang HH. Sudden death in young athletes. Arch Pathol Lab Med. 1982;106:168-170.
9. James TN, Froggatt P, Marshall TK. Sudden death in young athletes. Ann Intern Med. 1967;67:1013-1021.
10. Furlanello F, Bettini R, Cozzi F, Del Favero A, Disertori M, Vergara G, Durante GB, Guarnerio M, Inama G, Thiene G. Ventricular arrhythmias and sudden death in athletes. Ann N Y Acad Sci. 1984;427:253-279.
11. Maron BJ, Epstein SE, Roberts WC. Causes of sudden death in competitive athletes. J Am Coll Cardiol. 1986;7:204-214.
12. Drory Y, Turetz Y, Hiss Y, Lev B, Fisman EZ, Pines A, Kramer MR. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol. 1991;68:1388-1392.
13. Topaz O, Edwards JE. Pathologic features of sudden death in children, adolescents, and young adults. Chest. 1985;87:476-482.
14. Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med. 1996;334:1039-1044.
15. McCaffrey FM, Braden DS, Strong WB. Sudden cardiac death in young athletes: a review. Am J Dis Child. 1991;145:177-183.
16. Thompson PD, Stern MP, Williams P, Duncan K, Haskell WL, Wood PD. Death during jogging or running: a study of 18 cases. JAMA. 1979;242:1265-1267.
17. Thompson PD, Funk EJ, Carleton RA, Sturner WQ. Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA. 1982;247:2535-2538.
18. Waller BF, Roberts WC. Sudden death while running in conditioned runners aged 40 years or over. Am J Cardiol. 1980;45:1292-1300.
19. Virmani R, Robinowitz M, McAllister HA Jr. Nontraumatic death in joggers: a series of 30 patients at autopsy. Am J Med. 1982;72:874-882.
20. Maron BJ, Mitchell JH. Revised eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 1994;24:848-850.
21. Maron BJ, Garson A. Arrhythmias and sudden cardiac death in elite athletes. Cardiol Rev. 1994;2:26-32.
22. Maron BJ, Isner JM, McKenna WJ. 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse. J Am Coll Cardiol. 1994;24:880-885.
23. Cheitlin MD, De Castro CM, McAllister HA. Sudden death as a complication of anomalous left coronary origin from the anterior sinus of Valsalva: a not-so-minor congenital anomaly. Circulation. 1974:50:780-787.
24. Roberts WC. Congenital coronary arterial anomalies unassociated with major anomalies of the heart or great vessels. In: Adult Congenital Heart Disease. Philadelphia, Pa: FA Davis Co; 1987:583.
25. Kark JA, Posey DM, Schumacher HR, Ruehle CJ. Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med. 1987;317:781-787.
26. Maron BJ, Poliac L, Kaplan JA, Mueller FO. Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med. 1995;333:337-342.
27. Virmani R, Robinowitz M, Smialek JE, Smyth DF. Cardiovascular effects of cocaine: an autopsy study of 40 patients. Am Heart J. 1988;115:1068-1076.
28. Isner JM, Estes NA III, Thompson PD, Costanzo-Nordin MR, Subramanian R, Miller G, Katsas G, Sweeney K, Sturner WQ. Acute cardiac events temporally related to cocaine abuse. N Engl J Med. 1986;315:1438-1443.
29. Kaplan NM, Deveraux RB, Miller HS Jr. 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities, Task Force 4: systemic hypertension. J Am Coll Cardiol. 1994;24:885-888.
30. Driscoll DJ, Edwards WD. Sudden unexpected death in children and adolescents. J Am Coll Cardiol. 1985;5(suppl):118B-121B.
31. Maron BJ, Gardin JM, Flack JM, Gidding SS, Bild DE, Kurosaki TT. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study - Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785-789.
32. Maron BJ, Poliac LC, Roberts WC. Risk for sudden cardiac death associated with marathon running. J Am Coll Cardiol. 1996;28:428-431.
33. Maron BJ, Brown RW, McGrew CA, Mitten MJ, Caplan AL, Hutter AM Jr. Ethical, legal and practical considerations affecting medical decision-making in competitive athletes. J Am Coll Cardiol. 1994;24:854-860.
34. Mitten MJ. Team physicians and competitive athletes: allocating legal responsibility for athletic injuries. U Pitt L Rev. 1993;55:129-169.
35. Smith DM, Kovan JR, Rich BSE, Tanner SM. Preparticipation physical evaluation. Phys Sports Med. In press.
36. Dyment PG, ed. Sports Medicine: Health Care for Young Athletes. 2nd ed. Elk Grove Village, Ill: American Academy of Pediatrics; 1991.
37. Hulse E, Strong WB. Preparticipation evaluation for athletes. Pediatr Rev. 1987;9:173-182.
38. DuRant RH, Seymore C, Linder CW, Jay S. The preparticipation examination of athletes: comparison of single and multiple examiners. Am J Dis Child. 1985;139:657-661.
39. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, Williams WG. Hypertrophic cardiomyopathy: the importance of the site and extent of hypertrophy - a review. Prog Cardiovasc Dis. 1985;28:1-83.
40. Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy, 1. N Engl J Med. 1987;316:780-789
41. Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology. and therapy, 2. N Engl J Med. 1987;316:844-852.
42. Louie EK, Edwards LC III. Hypertrophic cardiomyopathy. Prog Cardiovasc Dis. 1994;36:275-308.
43. Maron BJ, Klues HG. Surviving competitive athletics with hypertrophic cardiomyopathy. Am J Cardiol. 1994;73:1098-1104.
44. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol. 1995;26:1699-1708.
45. Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG. A molecular basis for familial hypertrophic cardiomyopathy: a β-cardiac myosin heavy chain gene missense mutation. Cell. 1990;62:999-1006.
46. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 1994;77:701-712.
47. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:434-437.
48. Gaither NS, Rogan KM, Stajduhar K, Banks AK, Hull RW, Whitsitt T, Vernalis MN. Anomalous origin and course of coronary arteries in adults: identification and improved imaging utilizing transesophageal echocardiography. Am Heart J. 1991;122:69-75.
49. Maron BJ, Leon MB, Swain JA, Cannon RO III, Pelliccia A. Prospective identification by two-dimensional echocardiography of anomalous origin of the left main coronary artery from the right sinus of Valsalva. Am J Cardiol. 1991;68:140-142.
50. Ricci C, Longo R, Pagnan L, Dalla Palma L, Pinamonti B, Camerini F, Bussani R, Silvestri F. Magnetic resonance imaging in right ventricular dysplasia. Am J Cardiol. 1992;70:1589-1595.
51. McKenna WJ, Thiene G, Nava A, Fontaliran R, Blomstrom-Lundqvist C, Fontaine G, Camerini F, on behalf of the Task Force of the Working Group for the Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J. 1994;71:215-218.
52. Epstein SE, Maron BJ. Sudden death and the competitive athlete: perspectives on preparticipation screening studies. J Am Coll Cardiol. 1986;7:220-230.
53. Weidenbener EJ, Krauss MD, Waller BF, Taliercio CP. Incorporation of screening echocardiography in the preparticipation exam. Clin J Sports Med. 1995;5:86-89.
54. Feinstein RA, Colvin E, Oh MK. Echocardiographic screening as part of a preparticipation examination. Clin J Sports Med. 1993;3:149-152.
55. Risser WL, Hoffman HM, Bellah GG Jr, Green LW. A cost-benefit analysis of preparticipation sports examination of adolescent athletes. J Sch Health. 1985;55:270-273.
56. Murry PM, Cantwell JD, Heath DL, Shoop J. The role of limited echocardiography in screening athletes. Am J Cardiol. 1995;76:849-850.
57. Huston TP, Puffer JC, Rodney WM. The athletic heart syndrome. N Engl J Med. 1985;313:24-32.
58. Maron BJ. Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol. 1986;7:190-203.
59. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med. 1991;324:295-301.
60. Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes: insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation. 1995;91:1596-1601.
61. Maron BJ, Spirito P, Wesley Y, Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med. 1986;315:610-614.
62. LaCorte MA, Boxer RA, Gottesfeld IB, Singh S, Strong M, Mandell L. EKG screening program for school athletes. Clin Cardiol. 1989;12:42-44.
63. Maron BJ, Bodison SA, Wesley YE, Tucker E, Green KJ. Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease. J Am Coll Cardiol. 1987;10:1214-1221.
64. Maron BJ, Wolfson JK, Ciró E, Spirito P. Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by two-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol. 1983;51:189-194.
65. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, Weitkamp L, Vincent GM, Garson A Jr, et al. The long QT syndrome: prospective longitudinal study of 328 families. Circulation, 1991;84:1136-1144.
66. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med. 1992;327:846-852.
67. Zehender M, Meinertz T, Keul J, Just H. ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance. Am Heart J. 1990;119:1378-1391.
68. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979;300:1350-1358.
69. Lewis JF, Maron BJ, Diggs JA, Spencer JE, Mehrotra PP, Curry CL. Preparticipation echocardiographic screening for cardiovascular disease in a large, predominantly black population of collegiate athletes. Am J Cardiol. 1989;64:1029-1033.
70. Pelliccia A, Maron BJ. Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. Am J Cardiol. 1995;75:827-829.
71. Pelliccia A, Maron BJ, Culasso F, Spataro A, Caselli G. Athlete's heart in women: echocardiographic characterization of highly trained elite female athletes. JAMA. 1996;276:211-215.